Abstract
Elevated lipoprotein (a) concentrations are independent risk factors of coronary heart disease or stroke in young adults. To claify its role in childhood thrombosis, Lp (a) was measured in a population with arterial or venous thrombosis. Increased Lp (a) was diagnosed in eight of 36 children with arterial and five out of 36 children with venous thrombosis. Data of this study indicate that increased Lp (a) concentrations play an important role in childhood thrombosis.
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Armstrong VW, Walli AK, Seidel D (1985) Isolation, characterization and uptake in human fibroblasts of an apo (a)-free lipoprotein obtained on reduction of lipoprotein (a). J Lipid Res 26: 1314–1323
Seman LJ, Breckenridge WC (1986) Isolation an partial characterisation of apolipoprotein (a) from human lipoprotein (a). Biochem Cell Biol 64: 999–1009
Zenker G, Költringer P, Bone G, Niederkorn K, Pfeiffer K, Jürgens G (1986) Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 17: 942–945
Albers JJ, Hazzard WR (1974) Immunochemical quantification of human plasma Lp (a) lipoprotein. Lipids 9: 15–26
Berg K, Dahlen G, Frick MH (1974) Lp (a) lipoprotein and pre-beta 1 lipoprotein in patients with coronary heart disease. Clin Genet 6: 230–235
Seed M, Hoppichler F, Reaveley D, McCarthy S, Thomson GR, Boerwinkle E, Uterman G (1990) Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 322: 1494–1499
Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G (1990) Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 36: 20–23
Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M (1986) Lp (a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.Atherosclerosis 59: 199–204
Nagayama M, Shinohara Y, Nagayama T (1994) Lipoprotein (a) and ischemic cerebrovascular disease in young adults. Stroke 25: 74–78
Jürgens G, Költringer P (1994) Cerebrovascular disease and Lp (a): its role in atherosclerotic plaque formation and vessel wall elasticity of the carotid arteries. Chem Phys Lipids 68: 429–434
Woo J, Lau E, Lamm CWK et al (1991) Hypertension, lipoprotein (a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke 22: 203–208
Margaglione M, Di Minno G, Grandone E et al (1996) Plasma lipoprotein (a) levels in subjects attending a metabolic ward. Arterioscier Thromb Vasc Biol 16: 120–128
Hoff HF, Beck GJ, Skibinski CI, Jürgens G, O’Neil J, Kramer J, Lytle B (1988) Serum Lp (a) levels as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 77: 1238–1244
Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U (1989) Detection and quantification of lipoprotein (a) in the arterial: wall of 107 coronary by-pass patients. Arteriosclerosis 9: 579–592
Andrew M, Paes B, Milner R, Johnston M (1990)Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12: 95–104
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80: 1998–2005
Nowak-Göttl U, Funk M, Mosch G, Wegerich B, Kornhuber B, Breddin HK (1994) Univariatetolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasmi- nogen and a2-antiplasmin in children using the new automated coagulation laboratory (ACL) method. Klin Pädiatr 206: 437–439
Nowak-Göttl U, Koch HG, Aschka I et al (1996) Resistance to activated protein C ( APCR) in children with venous or arterial thromboembolism. Br J Haematol 92: 992–998
Berg K (1963) A new serum type system in man–the Lp system. Acta Pathol Microbiol Scand 59: 369–383
McLean JW, Tomlinson JE, Kuang WJ (1987) cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 300: 132–137
Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF (1989) A potential basis for the thrombotic risk associated with lipoprotein (a). Nature 339: 301–303
Utermann G (1989) The mysteries of lipoprotein (a). Science 246: 904–910
Cambillau M, Simon A, Amar J et al (1992) Serum Lp (a) as a discriminant marker of early atherosclerotic plaques at three extracoronary sites in hypercholestrolemic men. Arterioscl Throm 12: 1346–1352
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Findeisen, M., Vielhaber, H., Debus, O., Kurlemann, G., Nowak-Göttl, U. (1998). The Role of Apolipoprotein (a) in Childhood Thromboembolism. In: Scharrer, I., Schramm, W. (eds) 27. Hämophilie-Symposion Hamburg 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80403-8_74
Download citation
DOI: https://doi.org/10.1007/978-3-642-80403-8_74
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62915-3
Online ISBN: 978-3-642-80403-8
eBook Packages: Springer Book Archive